Publication | Closed Access
A pilot study: use of fludarabine for refractory dermatomyositis and polymyositis, and examination of endpoint measures.
58
Citations
0
References
1999
Year
A subset of patients with refractory myositis may benefit from fludarabine therapy and controlled trials are indicated. Refinement and validation of variables useful for following myositis patients await larger studies.